The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) trial: design and baseline characteristics of participants

Overview of attention for article published in Contemporary Clinical Trials, October 2025

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 6 X users

bluesky: 2 Bluesky users

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 2 Bluesky posts from 2 Bluesky users, with an upper bound of 134 followers.

RP @brandon-beaber.bsky.social: The TREAT-MS trial is an ongoing randomized trial to see if early use of higher-efficacy disease-modifying therapy (DMT) reduces later risk of disability in multiple sclerosis (MS). Link is baseline participants of the t…

The TREAT-MS trial is an ongoing randomized trial to see if early use of higher-efficacy disease-modifying therapy (DMT) reduces later risk of disability in multiple sclerosis (MS). Link is baseline participants of the trial participants. pubmed.ncbi.…

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.